Βιβλιογραφική Τεκμηρίωση:
1.mTOR: a pharmacologic target for autophagy regulation. Kim YC, Guan KL.J Clin Invest. 2015 Jan;125(1):25-32.
2.Akt/mammalian target of rapamycin signaling pathway regulates neurite outgrowth in cerebellar granule neurons stimulated by methylcobalamin. Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, Murase T, Yoshikawa H. Neurosci Lett. 2011 May 20;495(3):201-4.
3.Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A, Yu Y.Oncol Rep. 2018 Mar;39(3):1523-1531.
4. Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1. Kanayama M, Hayano T, Koebis M, Maeda T, Tabe Y, Horie S, Aiba A. Prostate. 2017 Nov;77(15):1489-1498.
mTOR signaling controls VGLUT2 expression to maintain pain hypersensitivity after tissue injury. Izumi Y, Sasaki M, Hashimoto S, Sawa T, Amaya F. Neuroscience. 2015 Sep 8. pii: S0306-4522(15)00823-4. doi: 10.1016/j.neuroscience.2015.09.013. [Epub ahead of print]
Role of mTOR in glioblastoma. Duzgun Z, Eroglu Z, Avci CB. Gene. 2015 Sep 1. pii: S0378-1119(15)01058-6. doi: 10.1016/j.gene.2015.08.060. [Epub ahead of print] Review.
Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma. Ma Z, Liu W, Zeng J, Zhou J, Guo P, Xie H, Yang Z, Zheng L, Xu S, Wang X, Chang LS, He D, Li L. Oncol Rep. 2015 Aug 26. doi: 10.3892/or.2015.4224. [Epub ahead of print]